CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
86 hedge funds and large institutions have $1.48B invested in China Biologic Products Holdings, Inc. in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
67% less call options, than puts
Call options by funds: $2.42M | Put options by funds: $7.32M
Holders
86
Holding in Top 10
1
Calls
$2.42M
Puts
$7.32M
Top Buyers
| 1 | +$64.3M | |
| 2 | +$56.3M | |
| 3 | +$43.2M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$41.5M |
| 5 |
BlackRock
New York
|
+$20.1M |
Top Sellers
| 1 | -$75.9M | |
| 2 | -$45.3M | |
| 3 | -$26M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$22.9M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$22.5M |